The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
A new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of certain aggressive lung and prostate cancers. (Photo from ...
Medicare covers screenings and treatment for prostate cancer, with Part A covering hospital care and Part B covering outpatient care and outpatient cancer medications. Original Medicare (parts A and B ...
Treatment choice for localized prostate cancer depends on cancer aggressiveness and quality-of-life factors, such as sexual functioning. Active surveillance is a safe option for appropriate patients, ...
Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...
President Biden is receiving radiation therapy as he battles an aggressive form of prostate cancer, a spokesperson told The Hill on Saturday. “As part of a treatment plan for prostate cancer, ...
Luisel Ricks-Santi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...
Former President Biden on Monday finished a round of radiation therapy to treat his aggressive former of prostate cancer, according to a Biden spokesperson. The course lasted several weeks, and the ...
Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. The former president's office said he has an "aggressive form" of the cancer, which has spread to his bones.
JongSoo Lee, Ph.D., Mathematics & Statistics, Kennedy College of Sciences, University of Massachusetts Lowell Camilla Pimentel, Ph.D., Public Health, Zuckerberg ...